SCHEMBL1103973

SCHEMBL1103973

CC(C)(C)OC(=O)N1CCC(COc2c(F)cc(C3CCNCC3)cc2F)CC1

nearest known ligand 0.56

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.47
FEN1 P39748 2/20 0.47
GPR119 Q8TDV5 9/20 0.47
DPP4 P27487 1/20 0.45
KDM4E B2RXH2 2/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
SCN9A Q15858 1/20 0.43
CHEK2 O96017 1/20 0.42
PKM P14618 1/20 0.41
BRD3 Q15059 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103974 0.85 GPR119 (0.54) ALOX5APFEN1GPR119SCN9A
SCHEMBL1103975 0.83 GPR119 (0.50) ALOX5APFEN1GPR119DPP4KDM4E
SCHEMBL1103979 0.81 GPR119 (0.48) ALOX5APFEN1GPR119DPP4SCN9A
SCHEMBL1103978 0.79 GPR119 (0.46) ALOX5APFEN1GPR119DPP4SCN9A
SCHEMBL1103977 0.78 GPR119 (0.55) ALOX5APFEN1GPR119CHEK2
SCHEMBL13535186 0.77 GPR119 (0.51) ALOX5APFEN1GPR119DPP4KDM4E
SCHEMBL1936255 0.77 GPR119 (0.49) ALOX5APFEN1GPR119KDM4EMAPT
SCHEMBL3113163 0.76 ALOX5AP (0.49) ALOX5APFEN1GPR119DPP4KDM4E
SCHEMBL20439010 0.76 KDM4E (0.55) GPR119DPP4KDM4EMAPTTHRB
SCHEMBL1935569 0.76 GPR119 (0.50) ALOX5APFEN1GPR119DPP4SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8258156-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2012-09-04 US disclosed
US-8258156-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2012-09-04 US disclosed
US-20120196844-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-02 US disclosed
US-8153635-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2012-04-10 US disclosed
US-8153635-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2012-04-10 US disclosed
US-20110224185-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC, a Delaware Limited Company (BM) 2011-09-15 US disclosed
US-20110224185-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC, a Delaware Limited Company (BM) 2011-09-15 US disclosed
US-20090270409-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-10-29 US disclosed
US-20090270409-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224185-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 ALOX5AP 943/4885FEN1 4876/4885GPR119 1/4885
US-20090270409-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 ALOX5AP 943/4885FEN1 4876/4885GPR119 1/4885
US-20120196844-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 ALOX5AP 943/4885FEN1 4876/4885GPR119 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.